Cargando…

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

Numerous studies conducted on obese humans and various rodent models of obesity have identified a correlation between hepatic lipid content and the development of insulin resistance in liver and other tissues. Despite a large body of the literature on this topic, the cause and effect relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Finck, Brian N., Hall, Angela M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529893/ https://www.ncbi.nlm.nih.gov/pubmed/26273583 http://dx.doi.org/10.1155/2015/104132

Ejemplares similares

Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
por: ter Horst, Kasper W., et al.
Publicado: (2017)

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
por: Geng, Yana, et al.
Publicado: (2021)

Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
por: Gorden, D. Lee, et al.
Publicado: (2011)

Drug-induced and postnatal hypothyroidism impairs the accumulation of diacylglycerol in liver and liver cell plasma membranes
por: Krasilnikova, Oksana A, et al.
Publicado: (2002)

Hepatic Notch Signaling Correlates With Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Valenti, Luca, et al.
Publicado: (2013)

Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
por: Minowa, Kei, et al.
Publicado: (2023)

Abrogating Monoacylglycerol Acyltransferase Activity in Liver Improves Glucose Tolerance and Hepatic Insulin Signaling in Obese Mice
por: Hall, Angela M., et al.
Publicado: (2014)

Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism
por: Chalhoub, Gabriel, et al.
Publicado: (2023)

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
por: Visser, M. E., et al.
Publicado: (2011)

Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis
por: Finck, Brian N.
Publicado: (2018)

Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice
por: Abulizi, Abudukadier, et al.
Publicado: (2020)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
por: Kotronen, Anna, et al.
Publicado: (2009)

Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
por: Dongiovanni, P., et al.
Publicado: (2017)

Ectopic Fat Accumulation and Distant Organ-Specific Insulin Resistance in Japanese People with Nonalcoholic Fatty Liver Disease
por: Kato, Ken-ichiro, et al.
Publicado: (2014)

Characteristics of hepatic insulin‐sensitive nonalcoholic fatty liver disease
por: Shigiyama, Fumika, et al.
Publicado: (2017)

Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice
por: Ando, Ayumi, et al.
Publicado: (2019)

mRNA expression of diacylglycerol kinase isoforms in insulin-sensitive tissues: effects of obesity and insulin resistance
por: Mannerås-Holm, Louise, et al.
Publicado: (2015)

Treating fatty liver disease by modulating mitochondrial pyruvate metabolism
por: Colca, Jerry R., et al.
Publicado: (2017)

Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease
por: Shannon, Chris E., et al.
Publicado: (2020)

A high oleic sunflower oil fatty acid esters of plant sterols mixed with dietary diacylglycerol reduces plasma insulin and body fat accumulation in Psammomys obesus
por: Ziv, Ehud, et al.
Publicado: (2009)

AGPAT2 interaction with CDP-diacylglycerol synthases promotes the flux of fatty acids through the CDP-diacylglycerol pathway
por: Mak, Hoi Yin, et al.
Publicado: (2021)

The Increased Activity of Liver Lysosomal Lipase in Nonalcoholic Fatty Liver Disease Contributes to the Development of Hepatic Insulin Resistance
por: Cahova, Monika, et al.
Publicado: (2012)

Nonalcoholic fatty liver disease and insulin resistance in children
por: Song, Kyungchul, et al.
Publicado: (2023)

Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation
por: Franko, Andras, et al.
Publicado: (2018)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Treating fatty liver and insulin resistance
por: Perry, Rachel J., et al.
Publicado: (2013)

GPAT Gene Silencing in Muscle Reduces Diacylglycerols Content and Improves Insulin Action in Diet-Induced Insulin Resistance
por: Kojta, Iwona, et al.
Publicado: (2020)

Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease
por: Rebelos, Eleni, et al.
Publicado: (2021)

Structural insights into perilipin 3 membrane association in response to diacylglycerol accumulation
por: Choi, Yong Mi, et al.
Publicado: (2023)

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
por: Baumeier, Christian, et al.
Publicado: (2017)

Effect of diacylglycerol acyltransferase 2 overexpression in 3T3-L1 is associated to an increase in mono-unsaturated fatty acid accumulation
por: Zhang, Zhiqi, et al.
Publicado: (2014)

Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
por: Niranjan, Sitara, et al.
Publicado: (2023)

Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease
por: Chan, Mandy M., et al.
Publicado: (2023)

The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice
por: Gart, Eveline, et al.
Publicado: (2022)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
por: Amati, Francesca, et al.
Publicado: (2011)

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
por: Liu, Qing, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j2f0hg8rbmptql88vit6sj96u2